Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabio Angeli

Showing results (71-80 of 313) with videos related to

Pageof 32
Sort By:
Journal of Hypertension|January 29, 2015
Interpretation of ambulatory blood pressure profile: a prognostic approach for clinical practiceFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
European Journal of Internal Medicine|November 10, 2022
The new phase of pandemic: Are BA.2.75 and BQ.1 competitive variants? An in silico evaluationMartina Zappa, Paolo Verdecchia, Fabio Angeli
American Journal of Hypertension|September 20, 2021
African Ancestry and Uncontrolled Hypertension: Current Knowledge and Future PerspectivesFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
European Journal of Internal Medicine|January 26, 2024
The lowest well tolerated blood pressure: A personalized target for all?Paolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi
Journal of Hypertension|June 11, 2011
Lowering blood pressure with β-blockers in peripheral artery disease: the importance of comorbidityFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 23, 2011
Finding a place for aliskiren in the wide spectrum of blood pressure lowering agentsFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
Journal of Hypertension|February 10, 2012
Microcirculation and left-ventricular hypertrophyFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
Hypertension (Dallas, Tex. : 1979)|February 15, 2022
Chronic Kidney Disease and Left Ventricular Hypertrophy. Potent Modifiers of the Prognostic Impact of Circadian Blood Pressure ChangesPaolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi
Journal of Cardiovascular Development and Disease|January 20, 2023
Rethinking the Role of the Renin-Angiotensin System in the Pandemic Era of SARS-CoV-2Fabio Angeli, Martina Zappa, Paolo Verdecchia
Journal of Hypertension|May 3, 2013
Protein intake in type 1 diabetes: putting controversies into perspectivesFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
Pageof 32

Showing results (71-80 of 313) with videos related to

Sort By:
Pageof 32
Journal of Hypertension|January 29, 2015
Interpretation of ambulatory blood pressure profile: a prognostic approach for clinical practiceFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
European Journal of Internal Medicine|November 10, 2022
The new phase of pandemic: Are BA.2.75 and BQ.1 competitive variants? An in silico evaluationMartina Zappa, Paolo Verdecchia, Fabio Angeli
American Journal of Hypertension|September 20, 2021
African Ancestry and Uncontrolled Hypertension: Current Knowledge and Future PerspectivesFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
European Journal of Internal Medicine|January 26, 2024
The lowest well tolerated blood pressure: A personalized target for all?Paolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi
Journal of Hypertension|June 11, 2011
Lowering blood pressure with β-blockers in peripheral artery disease: the importance of comorbidityFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 23, 2011
Finding a place for aliskiren in the wide spectrum of blood pressure lowering agentsFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
Journal of Hypertension|February 10, 2012
Microcirculation and left-ventricular hypertrophyFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
Hypertension (Dallas, Tex. : 1979)|February 15, 2022
Chronic Kidney Disease and Left Ventricular Hypertrophy. Potent Modifiers of the Prognostic Impact of Circadian Blood Pressure ChangesPaolo Verdecchia, Fabio Angeli, Gianpaolo Reboldi
Journal of Cardiovascular Development and Disease|January 20, 2023
Rethinking the Role of the Renin-Angiotensin System in the Pandemic Era of SARS-CoV-2Fabio Angeli, Martina Zappa, Paolo Verdecchia
Journal of Hypertension|May 3, 2013
Protein intake in type 1 diabetes: putting controversies into perspectivesFabio Angeli, Gianpaolo Reboldi, Paolo Verdecchia
Pageof 32